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niche (Kopp et al., 2005). In addition,
identification of molecular markers to
track the itinerary of a true HSC within
theBM in real time is necessary in order
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The role of endogenous mesenchymal stem cells (MSCs) is enigmatic. Recently in Cell, Takashima
et al. (2007) addressed the biological origin of MSCs and showed that they are generated in waves,
with the neuroepithelium unexpectedly providing the first wave and a second wave of nonneural-
derived MSCs taking precedence in the adult.Many key questions in stem cell biol-
ogy revolve around the origin, tissue
home, and physiological role of the
adult stem cell populations that have
been identified over the past several
decades. For some, such as hemato-
poietic and epidermal stem cells, their
niches and biological roles are rela-
tively clear. For others, such as adult
neural stem cells, we are just begin-
ning to understand their importance
in the adult organism. And for yet
others, we still know little. Among this
latter group are mesenchymal stem
cells (MSCs), which, while intensively
studied in culture, have remained
elusive with regard to their in vivo biol-
ogy. In this regard, a recent paper in
Cell by Takashima et al. (2007) has
addressed the in vivo biology of
MSCs, with some surprising and unex-
pected conclusions.
MSCswere originally defined by two
properties they display when cultured:the ability to proliferate substantially
as clones and to differentiate into
mesenchymal lineages, including
osteocytes, chondrocytes, and adipo-
cytes (Prockop, 1997). Subsequent
work defined markers that enabled
the prospective isolation, enrichment,
and characterization of MSCs (Gron-
thos et al., 1994; Pittenger et al.,
1999) and ultimately demonstrated
their utility for a number of cell-
replacement applications (Deans and
Moseley, 2000; Horwitz et al., 2002).
However, we still know little about their
in vivo biology. For example, what is
the niche(s) for MSCs in adult tissues?
What role do MSCs play in tissue
turnover and/or in response to injury?
Where do MSCs come from? It is this
final question that is the subject of
the paper by Takashima et al. (2007).
Mesenchymal tissues such as the
skeleton and dermis are known to
derive from two developmental ori-Cell Stem Cegins—mesoderm for most of the
body, and cranial neural crest for the
face, front of the skull, and some
upper-trunk structures. It has there-
fore been assumed, but never shown,
that MSCs largely derive from meso-
derm (Dennis and Charbord, 2002).
Takashima et al. (2007) therefore
chose to ask how MSCs arise, initially
by studying ES cells. Using protocols
that differentiate ES cells to mesoder-
mal versus neural/neural crest line-
ages, they demonstrated that both
lineages generated PDGFRa-positive
cells (a marker for MSCs) that could
make adipocytes. However, the sur-
prise came when they found that the
neural, but not mesodermal, differenti-
ations contained MSCs that could
proliferate extensively as multipotent
clones. Moreover, these MSCs were
generated from cells expressing
Sox1, a definitive marker for neuroepi-
thelium, demonstrating their neuralll 1, August 2007 ª2007 Elsevier Inc. 129
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Previewsorigin. Thus, for ES cells, differentia-
tion along a mesodermal pathway did
not generate MSCs, but differentiation
toward a neural/neural crest fate did.
These results were surprising from
two perspectives. First, they sug-
gested that MSCsmight primarily orig-
inate from the neuroepithelium in vivo.
Second, they implied that mesodermal
differentiation into mesenchymal cell
types did not necessarily require an
MSC intermediate.
Takashima et al. (2007) then asked
about the in vivo relevance of these
findings by using lineage tracing
approaches. They first made embryos
expressing GFP from the Sox1 locus.
They then isolated the trunk of these
embryos at E9.5 (thereby excluding
the cranial neural crest, which is known
to generate mesenchymal cells) and
demonstrated that Sox1-GFP-positive
cells gave rise to PDGFRa-positive
MSCs. In contrast, GFP-negative,
PDGFRa-positive cells (which ex-
pressed mesodermal markers) did not
generate MSCs, although they did
make adipocytes. Thus, just as seen
with ES cells, MSCs could be
generated from trunk neuroepithelial
cells, but not from mesodermal cells in
midgestation embryos.
These experiments demonstrated
that trunk neuroepithelium could
make MSCs. To demonstrate that it
actually did so, the authors made
Sox1-Cre/YFP mice in which the prog-
eny of Sox1-positive neuroepithelial
cells were persistently labeled. They
also used P0-Cre/YFP mice (P0 is
a neural crest marker) in which the
progeny of P0-positive neural crest
stem cells were persistently labeled.
Analysis of these mice demonstrated
that a large portion of PDGFRa-posi-
tive cells in the E14.5 trunk were in
fact neuroepithelium and/or neural
crest-derived and that a subpopulation
of these were MSCs. However, while
pursuing these experiments, the
authors made a second unexpected
finding: many fewer (8-fold) PDGFRa-130 Cell Stem Cell 1, August 2007 ª2007positive cells came from the neuroepi-
thelium than from the neural crest.
Trunk neural crest is thought to be
entirely neuroepithelium derived, but
this observation raises the intriguing
possibility that this particular subpop-
ulation of neural crest has a different
origin.
Finally, Takashima et al. (2007)
asked what contribution these neural-
derived MSCs made to the postnatal
bone marrow, the most-well-charac-
terized MSC source. They showed
that neural MSCs were still present in
the bone marrow but that their
numbers declined so that they repre-
sented only a very small fraction of
PDGFRa-positive bone cells by adult-
hood. Thus, by inference, the relative
importance of the neuroepithelium/
neural crest-derived MSCs declined
over development, with a later wave
of MSCs becoming increasingly
important.
These studies therefore support the
surprising overall conclusion that the
first wave of MSCs in the embryo
derive from the neuroepithelium and
neural crest, including the trunk neural
crest, and that a second wave of
MSCs from an unknown source then
takes precedence following birth.
These findings also define a stem cell
hierarchy, in which neuroepithelial
stem cells give rise to neural crest
stem cells that in turn are the parents
of MSCs. However, perhaps as impor-
tant as the conclusions are the ques-
tions raised by this study. First, what
is the other, later source(s) of MSCs?
Mesoderm immediately comes to
mind, but data presented here argue
that mesoderm can generate mesen-
chymal cell types without transiting
through an MSC intermediate. More-
over, recent work has suggested that
hematopoietic stem cells can generate
MSCs (Ogawa et al., 2006). Thus, the
origin of most adult MSCs is still an
open question. Second, do MSCs of
different developmental origins differ
in either their properties or biologicalElsevier Inc.roles? For example, perhaps neural
crest-derived MSCs are important for
genesis of embryonic tissues, while
mesodermally derived MSCs are
important for tissue maintenance and
repair. Third, do the stem cell hierar-
chies defined in the embryo still exist
in adult tissues, and if so, are they
one-way hierarchies? For example,
perhaps adult neural crest stem cells
that persist in mesenchymal tissues
(Fernandes et al., 2004) are the parents
of some adult MSCs. Moreover, if
MSCs could dedifferentiate to resem-
ble their neural crest stem cell parents,
then perhaps this would explain some
of the unexpected potency of bone
marrow-derived MSCs (Jiang et al.,
2002). Answering these questions
promises both to generate fundamen-
tal information about MSCs and to
provide insights into the biology of
adult stem cells in general.
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